Novo, Lilly shares rise as Trump obesity drug deal nears

Shares of obesity drugmakers Eli Lilly and Novo Nordisk rose early on Thursday in anticipation of a White House deal that would reduce prices of their blockbuster weight-loss treatments in return for ... ...